Terrence C. Kearney

Terrence C. Kearney, listed as board member, has filed trades across 3 companies (mainly through SEC (Form 4)), most often in Vertex Pharmaceuticals INC / MA, Acceleron Pharma Inc and AveXis, Inc. We count 30 filings; the first trade dates from 1 June 2016 and the latest from 10 August 2023.

Every open-market trade on record is a sale: 10 sales worth €13.2M. Besides market trades, the filings include 10 share grants and 8 option exercises.

The record was last updated on 14 August 2023 with an option exercise (€1.2M) in Vertex Pharmaceuticals INC / MA. The median gap between a trade and its publication by SEC (Form 4) is 3 days. Section 16 rules allow two business days to file each Form 4. A sale on its own says little: insiders also sell to pay tax, fund a purchase or diversify. This summary is built from SEC (Form 4) disclosures alone and does not predict where the share price will go.